Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy

Ir Med J. 2013 Jan;106(1):24-5.

Abstract

Impulse control disorders (ICDs) are a known side effect of dopamine replacement therapy in patients with Parkinson's disease (PD). They can have devastating consequences for patients and their families.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Amantadine / adverse effects
  • Antiparkinson Agents / adverse effects*
  • Benzothiazoles / adverse effects
  • Carbidopa / adverse effects
  • Catechols / adverse effects
  • Disruptive, Impulse Control, and Conduct Disorders / chemically induced*
  • Drug Combinations
  • Female
  • Humans
  • Indans / adverse effects
  • Indoles / adverse effects
  • Levodopa / adverse effects
  • Male
  • Middle Aged
  • Neuroprotective Agents / adverse effects*
  • Parkinson Disease / drug therapy*
  • Pramipexole
  • Selegiline / adverse effects

Substances

  • Antiparkinson Agents
  • Benzothiazoles
  • Catechols
  • Drug Combinations
  • Indans
  • Indoles
  • Neuroprotective Agents
  • Stalevo
  • rasagiline
  • ropinirole
  • Selegiline
  • Levodopa
  • Pramipexole
  • Amantadine
  • Carbidopa